SHARE ISSUE

Based on the power of attorney granted at the annual general meetings of
NattoPharma ASA ("NattoPharma" or "Company") on June 25, 2015 and May 20, 2016,
the Board of Directors of NattoPharma has in board proceedings June 24th, 2016
approved a share issue of 305 000 new shares, each with a face value of NOK 3
per share.
The share issue will be completed through issuance of new shares to leading
employees in accordance with the company’s incentive program according to the
following plan;

Name        Position /   Granted shares     Shares prior  Shares after
            Function                        to share      share issue
                                            issue
Daniel H.   CEO                             0
Rosenbaum                100.000                          100.000
Kjetil      CFO                             0
Ramsøy                   100.000                          100.000
Eric        VP Sales &                      0
Anderson    Marketing    50.000                           50.000
Rudi de     VP Sales                        0
Man         Europe &     30.000                           30.000
            Asia
William     VP Global                       0
Sommer      Development  25.000                           25.000
            and
            Regulatory

Price to be paid for each share is NOK 3 per share. The share issue is expected
to be completed within July 31st, 2016.

As a result, the share capital will be increased by NOK 915 000. The Company’s
new share capital after the share issue will be NOK 52 334 799 divided into
17 444 933 shares, each with a face value of NOK 3.

* * *

For more information, please contact:

Kjetil Ramsøy, Chief Financial Officer

E-mail: kjetil.ramsoy@nattopharma.com

This information is subject of the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.